更高价疫苗对侵袭性疾病肺炎链球菌抗菌药物耐药率的影响:基于国家参考实验室数据的回顾性分析,比利时,2018至2023年
基于比利时侵袭性肺炎链球菌国家参考实验室2018至2023年8123株分离株的回顾性分析,评估PCV15和PCV20新增血清型与抗菌药物耐药的关联。PCV20非PCV13血清型占IPD分离株37%,PCV15非PCV13血清型占7.4%。PCV20可能比PCV15带来更大的IPD总体发病率下降,对耐药的影响可能有限但可避免部分耐药或难治感染。
要点
- PCV20非PCV13血清型占IPD分离株37%(n=2992),PCV15非PCV13血清型占7.4%(n=597)。
- 非PCV20血清型中24%(508/2125)对青霉素耐药。
- PCV20接种对耐药的影响可能有限,但部分耐药或难治感染可被避免。
核心结论
- PCV20可能比PCV15带来更大的IPD总体发病率下降。
- PCV20接种对抗菌药物耐药的影响可能有限,但部分耐药或难治感染可被避免。
- 血清型替换可能导致低水平青霉素耐药感染增加,但其中大多数应仍可治疗。
研究设计与样本
- 回顾性分析,基于比利时侵袭性肺炎链球菌参考中心2018至2023年的实验室监测数据。
- 共获得8123株IPD分离株,其中8088株进行了血清分型和抗菌药物耐药检测。
- 采用多项逻辑回归评估疫苗血清型组与抗菌药物耐药的关联;当关联随患者年龄变化时,报告比值比(OR)的范围。
主要发现
- PCV15非PCV13血清型占IPD分离株7.4%(n=597),PCV20非PCV13血清型占37%(n=2992)。
- 非PCV20血清型中24%(508/2125)对青霉素耐药。
- 与非PCV20血清型相比,PCV15非PCV13血清型更常与红霉素耐药(OR:3.59-9.43)和四环素耐药(OR:2.00)相关,更常与甲氧苄啶/磺胺甲噁唑敏感(OR:0.11)相关。
- PCV20非PCV15血清型更常与阿莫西林耐药(OR:9.45)和头孢噻肟耐药(OR:5.06-82.38)相关,更常与红霉素敏感(OR:0.13-0.18)、四环素敏感(OR:0.71)和青霉素敏感(OR:0.05-0.46)相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDFifteen- and 20-valent pneumococcal conjugate vaccines (PCVs) offer broader protection against invasive pneumococcal disease (IPD) than PCV13. Adopting these vaccines may result in decreasing IPD incidence, antibiotic use and antimicrobial resistance (AMR) rates. If the additional serotypes in PCV15 and PCV20 are associated with AMR, AMR rate reduction could be greater than expected from reduced antibiotic consumption alone.AIMThis retrospective analysis assessed the association between AMR and non-PCV13 serotypes in PCV15 and PCV20.METHODSLaboratory-based surveillance data on 8,123 IPD isolates were obtained retrospectively from the Belgian Reference Centre for invasive Streptococcus pneumoniae. Isolates (n = 8,088) were serotyped and tested for AMR. Associations between vaccine serotype groups and AMR were evaluated by multinomial logistic regression. Where associations varied with patients' age, ranges of odds ratios (ORs) are presented.RESULTSPCV15-non-PCV13 and PCV20-non-PCV13 serotypes accounted for 7.4% (n = 597) and 37% (n = 2,992) of IPD isolates respectively. Of non-PCV20 serotypes, 24% (508/2,125) were penicillin resistant. Compared with non-PCV20 serotypes, PCV15-non-PCV13 serotypes were more often associated with erythromycin (ORs: 3.59-9.43) and tetracycline (OR: 2.00) resistance, and with trimethoprim/sulfamethoxazole (OR: 0.11) susceptibility. PCV20-non-PCV15 serotypes were more often associated with amoxicillin (OR: 9.45) and cefotaxime (ORs: 5.06-82.38) resistance, and with erythromycin (ORs: 0.13-0.18), tetracycline (OR: 0.71) and penicillin (ORs: 0.05-0.46) susceptibility.CONCLUSIONPCV20 may lead to a larger decrease in overall IPD incidence than PCV15. Although the PCV20 vaccination impact on AMR may be limited, some resistant or difficult to treat infections could be avoided. Serotype replacement might lead to infections with low level penicillin resistance increasing, but most of these should remain treatable.
引用
- Vermeulen H, Cuypers L, Catry B, et al. Higher valency vaccines' impact on antimicrobial resistance rates in Streptococcus pneumoniae causing invasive disease: a retrospective analysis based on national reference laboratory data, Belgium, 2018 to 2023. Euro Surveill. 2025. PMID: 41234191. doi:10.2807/1560-7917.ES.2025.30.45.2500179
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。